• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用体外方法和体内小鼠模型评估植物乳杆菌MTCC 5690和发酵乳杆菌MTCC 5689的安全性。

Assessing safety of Lactobacillus plantarum MTCC 5690 and Lactobacillus fermentum MTCC 5689 using in vitro approaches and an in vivo murine model.

作者信息

Pradhan Diwas, Singh Rajbir, Tyagi Ashish, H M Rashmi, Batish V K, Grover Sunita

机构信息

Molecular Biology Unit, Dairy Microbiology Division, ICAR-National Dairy Research Institute, Karnal, 132001, Haryana, India.

University of Louisville, 505 South Hancock Street # 323, Clinical Translational Research Bldg, Louisville, KY, 40202, USA.

出版信息

Regul Toxicol Pharmacol. 2019 Feb;101:1-11. doi: 10.1016/j.yrtph.2018.10.011. Epub 2018 Oct 24.

DOI:10.1016/j.yrtph.2018.10.011
PMID:30367905
Abstract

Lactobacilli have a long history of safe use in human nutrition, however, inclusion of any new strain, despite its safe usage evidence, warrants proper analysis of its safety and toxicity under the purview of existing regulations. In the present investigation, Lactobacillus plantarum MTCC 5690 and Lactobacillus fermentum MTCC 5689 were evaluated for their safety and toxicity using both in vitro and in vivo approaches. The in vitro assays included mucin degradation, hemolytic activity, biogenic amine production and platelet aggregation assay. The safety was also assessed using acute, subacute and subchronic assays, bacterial translocation studies, intravenous and intravenous administration and genotoxicity assay in murine model. The outcome of this toxicological safety assessment indicated that both the test strains lacked any harmful metabolic activity or any genotoxic effects. Furthermore, the results of oral toxicity studies in mice revealed that short term administration of high cell mass concentration of 10 cfu/animal as well as long term feeding of the probiotic strains did not alter any hematological, general health parameters or cause any organ specific disorder. Based upon these scientific assessments and supported by long history of safe use, both MTCC 5690 and MTCC 5689 may be considered safe for human consumption.

摘要

乳酸菌在人类营养中的安全使用历史悠久,然而,纳入任何新菌株,尽管有其安全使用的证据,但仍需在现有法规范围内对其安全性和毒性进行适当分析。在本研究中,使用体外和体内方法对植物乳杆菌MTCC 5690和发酵乳杆菌MTCC 5689的安全性和毒性进行了评估。体外试验包括粘蛋白降解、溶血活性、生物胺产生和血小板聚集试验。还使用急性、亚急性和亚慢性试验、细菌易位研究、静脉内和静脉注射以及小鼠模型中的遗传毒性试验来评估安全性。这种毒理学安全性评估的结果表明,两种受试菌株均缺乏任何有害的代谢活性或任何遗传毒性作用。此外,小鼠口服毒性研究的结果表明,以10 cfu/动物的高细胞质量浓度短期给药以及长期喂食益生菌菌株均未改变任何血液学、一般健康参数或引起任何器官特异性疾病。基于这些科学评估并得到长期安全使用历史的支持,MTCC 5690和MTCC 5689均可被认为对人类食用是安全的。

相似文献

1
Assessing safety of Lactobacillus plantarum MTCC 5690 and Lactobacillus fermentum MTCC 5689 using in vitro approaches and an in vivo murine model.使用体外方法和体内小鼠模型评估植物乳杆菌MTCC 5690和发酵乳杆菌MTCC 5689的安全性。
Regul Toxicol Pharmacol. 2019 Feb;101:1-11. doi: 10.1016/j.yrtph.2018.10.011. Epub 2018 Oct 24.
2
Assessing the Safety and Efficacy of Lactobacillus plantarum MTCC 5690 and Lactobacillus fermentum MTCC 5689 in Colitis Mouse Model.评估植物乳杆菌 MTCC 5690 和发酵乳杆菌 MTCC 5689 在结肠炎小鼠模型中的安全性和疗效。
Probiotics Antimicrob Proteins. 2019 Sep;11(3):910-920. doi: 10.1007/s12602-018-9489-5.
3
Safety Assessment of Potential Probiotic Lactobacillus fermentum MTCC-5898 in Murine Model after Repetitive Dose for 28 Days (Sub-Acute Exposure).潜在益生菌发酵乳杆菌 MTCC-5898 在重复剂量 28 天(亚急性暴露)后在小鼠模型中的安全性评估。
Probiotics Antimicrob Proteins. 2020 Mar;12(1):259-270. doi: 10.1007/s12602-019-09529-6.
4
Safety of a probiotic cheese containing Lactobacillus plantarum Tensia according to a variety of health indices in different age groups.含植物乳杆菌 Tensia 的益生菌干酪对不同年龄组多种健康指标的安全性。
J Dairy Sci. 2012 Oct;95(10):5495-509. doi: 10.3168/jds.2011-4756. Epub 2012 Aug 3.
5
Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice.高脂饮食喂养的 C57BL/6J 小鼠中源自印度肠道的益生菌菌株对葡萄糖耐量和胰岛素敏感性的改善作用。
Eur J Nutr. 2018 Feb;57(1):279-295. doi: 10.1007/s00394-016-1317-7. Epub 2016 Oct 18.
6
Pre-clinical safety and toxicity assessment of Limosilactobacillus fermentum NCDC 400 in murine model.Limosilactobacillus fermentum NCDC 400 在小鼠模型中的临床前安全性和毒性评估。
Microb Pathog. 2024 Apr;189:106589. doi: 10.1016/j.micpath.2024.106589. Epub 2024 Feb 19.
7
Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.两种微生物发酵乳杆菌LF15和植物乳杆菌LP01制成缓释阴道片,对患有细菌性阴道病的女性的有效性:一项试点研究。
J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S106-12. doi: 10.1097/MCG.0000000000000226.
8
In vitro probiotic properties of vaginal Lactobacillus fermentum MG901 and Lactobacillus plantarum MG989 against Candida albicans.阴道发酵乳杆菌 MG901 和植物乳杆菌 MG989 对白色念珠菌的体外益生菌特性。
Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:232-237. doi: 10.1016/j.ejogrb.2018.07.005. Epub 2018 Jul 9.
9
In vivo safety assessment of Lactobacillus fermentum strains, evaluation of their cholesterol-lowering ability and intestinal microbial modulation.Lactobacillus fermentum 菌株的体内安全性评估,降胆固醇能力及其对肠道微生物群的调节作用的评价。
J Sci Food Agric. 2020 Jan 30;100(2):705-713. doi: 10.1002/jsfa.10071. Epub 2019 Nov 9.
10
Safety Evaluation of a Novel Potentially Probiotic Limosilactobacillus fermentum in Rats.新型潜在益生菌发酵乳杆菌的大鼠安全性评价。
Probiotics Antimicrob Proteins. 2024 Jun;16(3):752-762. doi: 10.1007/s12602-023-10077-3. Epub 2023 Apr 29.

引用本文的文献

1
Functional and Safety Profile of and Development of Oral Fast-Disintegrating Tablets for Gut Microbiota Modulation.用于调节肠道微生物群的口腔速崩片的功能与安全性概况及研发
Pharmaceutics. 2025 Aug 1;17(8):1011. doi: 10.3390/pharmaceutics17081011.
2
Isolation, identification, and characterization of a marine strain with antimicrobial activity against .对一种具有抗……抗菌活性的海洋菌株进行分离、鉴定和特性分析。 (原文中“against”后内容缺失)
Front Microbiol. 2025 Jul 22;16:1636121. doi: 10.3389/fmicb.2025.1636121. eCollection 2025.
3
Safety Assessment of GABA-Producing Levilactobacillus brevis LAB6 MTCC 25662 and Its Anti-inflammatory Effects in Murine Macrophages.
产γ-氨基丁酸的短乳杆菌LAB6 MTCC 25662的安全性评估及其对小鼠巨噬细胞的抗炎作用
Probiotics Antimicrob Proteins. 2025 Jun 27. doi: 10.1007/s12602-025-10628-w.
4
Comprehensive safety assessment and therapeutic potential of Pediococcus acidilactici NMCC-B in attenuating arthritis progression.嗜酸乳杆菌NMCC - B在减缓关节炎进展中的综合安全性评估及治疗潜力
PLoS One. 2025 May 22;20(5):e0324060. doi: 10.1371/journal.pone.0324060. eCollection 2025.
5
Preclinical Safety Assessment of the Oral Administration of Lactobacillus plantarum GUANKE in Animal Models.植物乳杆菌观克口服给药在动物模型中的临床前安全性评估。
Probiotics Antimicrob Proteins. 2025 Mar 3. doi: 10.1007/s12602-025-10498-2.
6
Safety Evaluation and antioxidant potential of new probiotic strain (NMCC-path-14) in Balb/c mice by sub-acute repeated dose toxicity.通过亚急性重复剂量毒性试验对新益生菌菌株(NMCC-path-14)在Balb/c小鼠中的安全性评估及抗氧化潜力
Heliyon. 2024 Sep 27;10(19):e38581. doi: 10.1016/j.heliyon.2024.e38581. eCollection 2024 Oct 15.
7
Genome-based taxonomic identification and safety assessment of an Enterococcus strain isolated from a homemade dairy product.从自制乳制品中分离的肠球菌菌株的基于基因组的分类鉴定和安全性评估。
Int Microbiol. 2024 Oct;27(5):1513-1525. doi: 10.1007/s10123-024-00496-9. Epub 2024 Mar 11.
8
Characteristics of GB97 lysate isolated from porcine feces and its and effects on inflammation, intestinal barrier function, and gut microbiota composition in mice.从猪粪便中分离的 GB97 裂解物的特性及其对小鼠炎症、肠道屏障功能和肠道微生物组成的影响。
Microbiol Spectr. 2024 Jan 11;12(1):e0133423. doi: 10.1128/spectrum.01334-23. Epub 2023 Nov 29.
9
safety assessment of electrohydrodynamically encapsulated CRD7 and CRD11 for probiotics use.用于益生菌的电流体动力学封装CRD7和CRD11的安全性评估。
Curr Res Food Sci. 2023 Apr 22;6:100507. doi: 10.1016/j.crfs.2023.100507. eCollection 2023.
10
Topical Administration of (SkinDuo) Serum Improves Anti-Acne Properties.(SkinDuo)精华液的局部给药可改善抗痤疮特性。
Microorganisms. 2023 Feb 7;11(2):417. doi: 10.3390/microorganisms11020417.